Nakamura S, Taniguchi T, Suzuki F, Akagi Y, Muramatsu I
Department of Pharmacology, School of Medicine, Fukui Medical University, Matsuoka, Japan.
Br J Pharmacol. 1999 Jul;127(6):1367-74. doi: 10.1038/sj.bjp.0702675.
Subtypes of alpha1-adrenoceptor in rabbit iris have been examined in functional, binding and molecular biological experiments. In functional studies, exogenous and endogenous noradrenaline produced contractions of the iris dilator muscle. The contractile responses to noradrenaline were competitively antagonized by a range of alpha1-adrenoceptor antagonists (pA2 values): prazosin (8.1), WB4101 (8.2), BMY7378 (5.9), YM617 (9.5), JTH-601 (8.8), HV723 (7.8) and KMD-3213 (9.8). The same order of inhibitory potency was seen in the adrenergic responses to electrical stimulation. This affinity profile corresponds well to that of the putative alpha1L-adrenoceptor, which has been proposed in lower urinary tract tissues. In binding studies on rabbit iris membrane however, prazosin, KMD-3213 and WB4101 displayed high affinity (pKd or pKi: 9.6, 10.3, 9.6, respectively), and BMY7378 displayed low affinity (pKi: 6.9). These results show that the binding sites typically correspond to alpha1A-adrenoceptor subtype in character, and we could not detect the significant amount of alpha1L-adrenoceptor subtype. The expression of the three distinct mRNAs that encode proteins of alpha1a-, alpha1b- and alpha1d-adrenoceptors was studied using reverse transcription-polymerase chain reaction (RT-PCR). RT-PCR demonstrated the strongest expression of the alpha1a-adrenoceptor, weak expression of the alpha1b-adrenoceptor and undetectable expression of the alpha1d-adrenoceptor. The present study suggests that alpha1A-adrenoceptor is a major subtype detectable in binding and RT-PCR studies in rabbit iris, but that the adrenergic contractions of iris dilator muscle are mediated via activation of alpha1-adrenoceptor subtype having low affinity for prazosin and WB4101.
已通过功能、结合和分子生物学实验对兔虹膜中α1 -肾上腺素能受体的亚型进行了研究。在功能研究中,外源性和内源性去甲肾上腺素可引起虹膜开大肌收缩。去甲肾上腺素的收缩反应被一系列α1 -肾上腺素能受体拮抗剂竞争性拮抗(pA2值):哌唑嗪(8.1)、WB4101(8.2)、BMY7378(5.9)、YM617(9.5)、JTH - 601(8.8)、HV723(7.8)和KMD - 3213(9.8)。在对电刺激的肾上腺素能反应中也观察到了相同的抑制效力顺序。这种亲和力特征与在下尿路组织中提出的假定α1L -肾上腺素能受体的特征非常吻合。然而,在兔虹膜膜的结合研究中,哌唑嗪、KMD - 3213和WB4101显示出高亲和力(pKd或pKi分别为:9.6、10.3、9.6),而BMY7378显示出低亲和力(pKi:6.9)。这些结果表明,这些结合位点在性质上通常对应于α1A -肾上腺素能受体亚型,并且我们未检测到大量的α1L -肾上腺素能受体亚型。使用逆转录 - 聚合酶链反应(RT - PCR)研究了编码α1a -、α1b -和α1d -肾上腺素能受体蛋白的三种不同mRNA的表达。RT - PCR显示α1a -肾上腺素能受体表达最强,α1b -肾上腺素能受体表达较弱,而α1d -肾上腺素能受体未检测到表达。本研究表明,α1A -肾上腺素能受体是兔虹膜结合和RT - PCR研究中可检测到的主要亚型,但虹膜开大肌的肾上腺素能收缩是通过对哌唑嗪和WB4101具有低亲和力的α1 -肾上腺素能受体亚型的激活介导的。